RIA
KRYS icon

Regal Investment Advisors’s Krystal Biotech KRYS Stock Holding History

Regal Investment Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
4,050
-310
-7% -$82.5K 0.06% 282
2025
Q4 		$1.07M Buy
4,360
+44
+1% +$9.26K 0.06% 263
2025
Q3 		$762K Sell
4,316
-118
-3% -$17.7K 0.05% 311
2025
Q2 		$609K Buy
4,434
+127
+3% +$18.7K 0.05% 315
2025
Q1 		$777K Buy
+4,307
New +$724K 0.06% 252

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Regal Investment Advisors's KRYS Position: Q1 2026 in Review

Regal Investment Advisors reduced its Krystal Biotech (KRYS) stake by 7.1% in Q1 2026, selling an estimated $82.5K and leaving 4,050 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #282.

Regal Investment Advisors first reported a position in KRYS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.07M in Q4 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Regal Investment Advisors held 4,050 shares of Krystal Biotech worth $1.05M as of Q1 2026.
  • Regal Investment Advisors sold 310 Krystal Biotech shares in Q1 2026, an estimated $82.5K.
  • Krystal Biotech made up 0.06% of Regal Investment Advisors's portfolio in Q1 2026, its #282 holding.
  • Regal Investment Advisors first reported a position in Krystal Biotech in Q1 2025 and has held it in 5 quarters since.
  • Regal Investment Advisors's Krystal Biotech position peaked at $1.07M in Q4 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.